Explore
← New search
Filters:
Lung cancer
✕
tumor-informed ctdna/mrd detection (prophet algorithm)
✕
peripheral blood plasma
✕
clear all
1 matching publication(s)
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
PMID 38897205 · Cell Rep Med · 2024
L1
72/100